JP2010524928A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010524928A5 JP2010524928A5 JP2010504018A JP2010504018A JP2010524928A5 JP 2010524928 A5 JP2010524928 A5 JP 2010524928A5 JP 2010504018 A JP2010504018 A JP 2010504018A JP 2010504018 A JP2010504018 A JP 2010504018A JP 2010524928 A5 JP2010524928 A5 JP 2010524928A5
- Authority
- JP
- Japan
- Prior art keywords
- igfbp
- composition
- igf
- use according
- birth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92396307P | 2007-04-18 | 2007-04-18 | |
| US60/923,963 | 2007-04-18 | ||
| PCT/SE2008/050441 WO2008130315A1 (en) | 2007-04-18 | 2008-04-18 | Method and product for treatment and/or prevention of complications of prematurity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013189927A Division JP2013249317A (ja) | 2007-04-18 | 2013-09-13 | 未熟児合併症の治療及び／又は予防の方法と製品 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010524928A JP2010524928A (ja) | 2010-07-22 |
| JP2010524928A5 true JP2010524928A5 (enExample) | 2011-05-12 |
| JP5449134B2 JP5449134B2 (ja) | 2014-03-19 |
Family
ID=39875739
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010504018A Active JP5449134B2 (ja) | 2007-04-18 | 2008-04-18 | 未熟児合併症の治療及び／又は予防の方法と製品 |
| JP2013189927A Pending JP2013249317A (ja) | 2007-04-18 | 2013-09-13 | 未熟児合併症の治療及び／又は予防の方法と製品 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013189927A Pending JP2013249317A (ja) | 2007-04-18 | 2013-09-13 | 未熟児合併症の治療及び／又は予防の方法と製品 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US8518877B2 (enExample) |
| EP (1) | EP2148695B1 (enExample) |
| JP (2) | JP5449134B2 (enExample) |
| CN (1) | CN101969983B (enExample) |
| WO (1) | WO2008130315A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8518877B2 (en) * | 2007-04-18 | 2013-08-27 | Premacure Ab | Method and product for treatment and/or prevention of complications of prematurity |
| CA2888899C (en) | 2012-10-24 | 2023-02-21 | Japan Innovative Therapeutics, Inc. | Use of tryptase inhibitors in the treatment retinopathy of prematurity |
| US9510055B2 (en) | 2013-01-23 | 2016-11-29 | Sonos, Inc. | System and method for a media experience social interface |
| US20150220498A1 (en) | 2014-02-05 | 2015-08-06 | Sonos, Inc. | Remote Creation of a Playback Queue for a Future Event |
| US9679054B2 (en) | 2014-03-05 | 2017-06-13 | Sonos, Inc. | Webpage media playback |
| US20150324552A1 (en) | 2014-05-12 | 2015-11-12 | Sonos, Inc. | Share Restriction for Media Items |
| US20150356084A1 (en) | 2014-06-05 | 2015-12-10 | Sonos, Inc. | Social Queue |
| US9874997B2 (en) | 2014-08-08 | 2018-01-23 | Sonos, Inc. | Social playback queues |
| US9959087B2 (en) | 2014-09-24 | 2018-05-01 | Sonos, Inc. | Media item context from social media |
| US9690540B2 (en) | 2014-09-24 | 2017-06-27 | Sonos, Inc. | Social media queue |
| EP3114852A1 (en) | 2014-09-24 | 2017-01-11 | Sonos Inc. | Social media queue |
| US9667679B2 (en) | 2014-09-24 | 2017-05-30 | Sonos, Inc. | Indicating an association between a social-media account and a media playback system |
| WO2016049342A1 (en) | 2014-09-24 | 2016-03-31 | Sonos, Inc. | Social media connection recommendations based on playback information |
| US10645130B2 (en) | 2014-09-24 | 2020-05-05 | Sonos, Inc. | Playback updates |
| US9860286B2 (en) | 2014-09-24 | 2018-01-02 | Sonos, Inc. | Associating a captured image with a media item |
| US9723038B2 (en) | 2014-09-24 | 2017-08-01 | Sonos, Inc. | Social media connection recommendations based on playback information |
| EP4520828A3 (en) * | 2016-11-15 | 2025-07-09 | The Schepens Eye Research Institute, Inc. | Compositions and methods for the treatment of aberrant angiogenesis |
| KR20200097679A (ko) * | 2017-09-11 | 2020-08-19 | 샤이어 휴먼 지네틱 테라피즈 인크. | 만성 폐 질환 치료를 위한 방법 및 조성물 |
| WO2019099560A1 (en) | 2017-11-14 | 2019-05-23 | The Schepens Eye Research Institute, Inc. | Runx1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition |
| CA3141292A1 (en) * | 2019-05-28 | 2020-12-03 | Elgan Pharma Ltd | Compositions and methods for treating retinopathy |
| WO2023242442A1 (en) * | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Method of maturing/differentiating neurons and/or modulating the vagus nerve |
| WO2023242440A1 (en) * | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Treament of lungs in infants |
| KR20250079196A (ko) * | 2022-10-04 | 2025-06-04 | 오크 힐 바이오 리미티드 | Igf-1 복합체를 이용한 신생아 치료 방법 |
| WO2024160999A1 (en) * | 2023-02-03 | 2024-08-08 | Oak Hill Bio Limited | Treatment of kidney injury with igf-1 complex |
| IL322721A (en) * | 2023-02-14 | 2025-10-01 | Oak Hill Bio Ltd | Treatment of healing dysregulation in digestive tract tissue |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL71991A (en) | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
| US5187151A (en) * | 1991-02-12 | 1993-02-16 | Genentech, Inc. | Use of binding protein with igf-i as an anabolic growth promoting agent |
| AU4238493A (en) * | 1992-05-08 | 1993-12-13 | Thomas Jefferson University | IGF-1 analogs |
| US5563046A (en) | 1993-08-02 | 1996-10-08 | Celtrix Pharmaceuticals, Inc. | Fusion polypeptides and proteins |
| US5789547A (en) | 1995-06-07 | 1998-08-04 | Celtrix Pharmaceuticals, Inc. | Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding |
| US6121416A (en) * | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
| US6040292A (en) * | 1999-06-04 | 2000-03-21 | Celtrix Pharmaceuticals, Inc. | Methods for treating diabetes |
| AU2002239560B2 (en) * | 2000-11-28 | 2006-03-02 | Premacure Ab | Determination of risk and treatment of complications of prematurity |
| CA2614677A1 (en) * | 2005-07-15 | 2007-01-25 | Children's Medical Center Corporation | Methods for treating and diagnosing complications of premature birth |
| US8518877B2 (en) * | 2007-04-18 | 2013-08-27 | Premacure Ab | Method and product for treatment and/or prevention of complications of prematurity |
-
2008
- 2008-04-18 US US12/596,572 patent/US8518877B2/en active Active
- 2008-04-18 JP JP2010504018A patent/JP5449134B2/ja active Active
- 2008-04-18 WO PCT/SE2008/050441 patent/WO2008130315A1/en not_active Ceased
- 2008-04-18 EP EP08779242.0A patent/EP2148695B1/en active Active
- 2008-04-18 CN CN200880012284.9A patent/CN101969983B/zh active Active
-
2013
- 2013-07-24 US US13/949,750 patent/US20130310316A1/en not_active Abandoned
- 2013-09-13 JP JP2013189927A patent/JP2013249317A/ja active Pending
-
2015
- 2015-02-09 US US14/617,520 patent/US9463222B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9463222B2 (en) | Methods for treatment of complications of prematurity comprising administration of IGF-I and IGFBP-3 | |
| Kuriyam et al. | Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients | |
| CN103702672B (zh) | 用于预防和治疗糖尿病、低血糖症及相关病症的胰岛素和铬组合物 | |
| JP2006328074A5 (enExample) | ||
| ES2968043T3 (es) | Nuevos derivados de oxintomodulina y composición farmacéutica para el tratamiento de la obesidad que comprende la misma | |
| EP2329848B2 (en) | Lixisenatide as add-on therapy to insulin glargine and metformin for treating type 2 diabetes | |
| JP2011500850A5 (enExample) | ||
| UA106209C2 (en) | Choline cocrystal of 5-[(1z,2e)-2-methyl-3-phenylpropenylidene]-4-oxo-2-thioxo-3-thiazolidine acetic acid | |
| BR112020016613A2 (pt) | Composições para o tratamento de doença hepática gordurosa não alcóolica e esteato-hepatite não alcoólica | |
| CN101631558A (zh) | 基于艾塞那肽和达拉根的用于治疗糖尿病的药物、其用途和治疗模式 | |
| JP2024038042A (ja) | 肥満の治療および体重管理のためのｇｌｐ－１組成物 | |
| Duan et al. | Obesity, metabolic syndrome, and sleep disorders | |
| JP2020533344A (ja) | 慢性肺疾患を治療するための方法および組成物 | |
| EP4445909B1 (en) | Pharmaceutical formulation consisting of c-peptide combined with a bisphosphonate in a single form and its use in the treatment of osteosarcopenia | |
| WO2006130769A3 (en) | Methods for treatment of growth disorders | |
| US20260069586A1 (en) | Methods for reducing weight and preserving or increasing tissue lean mass in patients suffering from cushing's syndrome | |
| WO2026038132A1 (en) | Use of gpr119 agonists for the treatment of weight related disorders | |
| Chen et al. | Monitored Anesthesia Care Versus Intubated General Anesthesia for Open Heart Surgery Under Cardiopulmonary Bypass: A Prospective Cohort Study | |
| WO2026090182A1 (en) | Glp-1 receptor agonist and ursolic acid combinations and use thereof for increasing weight loss while improving muscle mass and strength | |
| CN121368489A (zh) | 用于治疗代谢障碍的glp-1类似物 | |
| AU2009238271B8 (en) | Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metformin | |
| Kudoh et al. | Endocrine response to surgical stress in three patients over 100 yr | |
| JP2003300899A (ja) | 肺高血圧治療薬 | |
| Celik et al. | Medical therapy of acromegaly in Turkey | |
| Wolden-Hanson | Peripheral ghrelin treatment stabilizes body weights of senescent male Brown Norway rats at baseline and after surgery |